US 9790274
Monoclonal antibodies targeting EpCAM for detection of prostate cancer lymph node metastases
granted A61KA61K47/6865A61K51/1066
Quick answer
US patent 9790274 (Monoclonal antibodies targeting EpCAM for detection of prostate cancer lymph node metastases) held by The Board of Regents of the University of Texas System expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K47/6865, A61K51/1066, A61K51/1093